ITC ended the last weekly session of January on a positive note, with the upside of over 1.1%. Next week, the stock will be in focus for its upcoming interim dividend and Q3 results.

ResMed Inc . (NYSE:RMD) reported its financial results for the second quarter of fiscal year 2025, exceeding analysts' expectations with an earnings per share (EPS) of $2.43, surpassing the forecasted ...